Chapter 1. Relevant Anatomy and Physiology ; 1.1 INFRANUCLEAR OCULAR MOTOR ANATOMY ; 1.1.1 Extraocular Muscles ; 1.1.2 Extraocular Muscle Pulleys ; 1.1.3 Orbital Tissues ; 1.2 SUPRANUCLEAR OCULAR MOTOR ANATOMY ; 1.2.1 Frontal Eye Fields ; 1.2.2 Superior Colliculus ; 1.2.3 Brainstem Nuclei ; 1.2.4 Vestibular Nuclei ; 1.2.5 Cerebellum ; 1.3 AFFERENT SYSTEM ; 1.3.1 Retina/Optic Nerve ; 1.3.2 Optic Nerve ; 1.3.3 Lateral Geniculate ; 1.3.4 Geniculostriate ; 1.3.5 Association Cortex ; 1.3.6 Ocular Motor Proprioception ; 1.4 EFFERENT SYSTEM ; 1.4.1 Smooth Pursuit System ; 1.4.2 Saccadic System ; 1.4.3 Vergence System ; 1.4.4 Vestibuloocular System ; Chapter 2. Infantile Nystagmus SyInfantile Nystagmus Syndromendrome ; 2.1 CHARACTERISTICS OF INS ; 2.1.1 History and Background ; 2.1.1.1 Ancient Descriptions and Theories ; 2.1.1.2 Connection to Fixation Attempt ; 2.1.1.3 Modern Physiological Investigation ; 2.1.2 Waveforms, Models, and Mechanisms ; 2.1.2.1 Waveform Types ; 2.1.2.2 Braking and Foveating Saccades ; 2.1.2.3 The Foveation Period ; 2.1.2.4 Foveation Accuracy ; 2.1.2.5 Target Acquisition Time ; 2.1.2.6 Smooth Pursuit ; 2.1.3 The Static Neutral Zone/Region ; 2.1.3.1 Latent Component ; 2.1.4 The Dynamic Neutral Zone/Region ; 2.1.4.1 Asymmetric, (a)Periodic Alternation ; 2.1.4.2 Optokinetic, Pursuit and Vestibuloocular Responses ; 2.1.5 The Null Angle/Zone/Region ; 2.1.6 The Convergence Null ; 2.1.7 The Saccadic Response ; 2.1.8 Static and Dynamic Head Posturing ; 2.1.9 Foveation and Visual Acuity (High Spatial Frequency Vision) ; 2.1.9.1. The eXpanded Nystagmus Acuity Function (NAFX) ; 2.1.9.1.1 NAFX vs. Gaze Angle ; 2.1.9.1.2 LFD and TID ; 2.1.10 Oscillopsia Suppression ; 2.1.10.1 Foveation Dynamics ; 2.1.10.2 Temporal Sampling ; 2.1.10.3 Efference Copy ; 2.1.11 Afferent Stimulation ; 2.1.11.1 Cutaneous Trigeminal Stimulation ; 2.1.11.2 Deep Muscle Stimulation ; 2.1.11.3 Contact Lenses ; 2.1.11.4 Biofeedback ; 2.1.12 Canine Nystagmus (Achiasmatic Belgian Sheepdog) ; 2.1.12.1 See-Saw ; 2.1.12.2 Pendular ; 2.1.12.3 Tenotomy & Reattachment Procedure ; 2.1.13 Canine Model of INS with RPE65 Retinal Degeneration (Briard) ; 2.2 ETIOLOGY OF INS ; 2.2.1 Familial (Gene Defect) ; 2.2.2 Developmental Disturbance Of Ocular Motor System with Associated Sensory System Deficit. ; 2.2.2.1 Albinism ; 2.2.2.2 Achiasma ; 2.2.2.3 Infantile Strabismus ; 2.2.2.4 Non-vectorial Visual Sensory Deficits ; 2.2.3 The Direct Cause(s) of INS with or without Sensory/Genetic Deficits ; 2.2.3.1 Loss of Smooth-Pursuit Damping ; 2.2.3.2 Tonic Vestibular-Optokinetic Imbalance ; 2.3 VISUAL FUNCTION DEFICITS AND MEASUREMENTS OF INS ; 2.3.1 Static Deficits ; 2.3.1.1 The eXpanded Nystagmus Acuity Function and Longest Foveation ; Domain Measures ; 2.3.2 Dynamic Deficits ; 2.3.2.1 Target Acquisition Time (Stationary Targets) ; 2.3.2.2 Target Acquisition Time (Moving Targets) ; 2.3.3 Clinical ; 2.3.3.1 Visual Acuity at Different Gaze Angles ; 2.4 TREATMENTS OF INS ; 2.4.1 Goals ; 2.4.2 Non-Surgical ; 2.4.2.1 Prisms ; 2.4.2.2 Contact Lenses ; 2.4.2.3 Drugs ; 2.4.2.4 Biofeedback ; 2.4.2.5 Gene-Transfer Therapy ; 2.4.3 Surgical ; 2.4.3.1 Four-Muscle Resection & Recession Procedure (Operation 1) ; (aka Kestenbaum, Anderson-Kestenbaum, or Anderson+Goto) ; 2.4.3.2 Two-Muscle Recession Procedure (Operation 1A) (aka Anderson) ; 2.4.3.3 Bilateral Medial Rectus Recession Procedure (Operation 8) ; 2.4.3.4 Tenotomy & Reattachment Procedure (Operation 6) ; Chapter 3. Fusion Maldevelopment Nystagmus Syndrome ; 3.1 CHARACTERISTICS OF FMNS ; 3.1.1 Waveforms, Models, and Mechanisms ; 3.1.1.1 Types (FMNS plus Nucleus of the Optic Tract) ; 3.1.1.2 The Fixating Eye ; 3.1.1.3 Target Foveation and Dual-Mode Fast Phases ; 3.1.1.4 Foveation Accuracy ; 3.1.2 Variation with Gaze Angle ; 3.1.3 Head Position ; 3.1.4 Foveation, NAFX, and Acuity ; 3.1.5 Efference Copy, Foveation, and Oscillopsia Suppression ; 3.2 TREATMENTS OF FMNS ; 3.2.1. Fixation Preference ; 3.2.2. Alexander's Law ; 3.2.3. Eye Muscle Surgery ; Chapter 4. Other Types of Nystagmus of Infancy ; 4.1 NYSTAGMUS BLOCKAGE SYNDROME ; 4.1.1 Characteristics of NBS ; 4.1.1.1 Multiple Types of Nystagmus ; 4.1.1.2 Waveforms and Mechanisms ; 4.1.1.2.1 Target Foveation ; 4.1.1.2.2 Foveation Accuracy ; 4.1.1.3 Purposive Esotropia ; 4.1.1.4 Head Position ; 4.1.1.5 Blockage Syndrome Types I and II ; 4.1.1.6 Foveation, NAFX, and Acuity ; 4.1.1.7 Efference Copy, Foveation, and Oscillopsia Suppression ; 4.1.2 Treatments of NBS ; 4.1.2.1. Fixation Preference ; 4.1.2.2. Alexander's Law ; 4.1.2.3. Surgical ; 4.1.2.3.1. Fixating Eye ; 4.2 SPASMUS NUTANS SYNDROME ; 4.2.1 Characteristics of SNS ; 4.2.1.1 Waveforms and Mechanisms ; 4.2.1.2 Variable Interocular Phase ; 4.2.1.3 Head Nodding ; 4.2.2 Treatment of SNS ; Chapter 5. Differential Diagnosis of Nystagmus In Infancy and Childhood ; 5.1 NYSTAGMUS WITHOUT ASSOCIATED NEUROLOGICAL DISEASE-<"BENIGN>" ; 5.1.1. Infantile Nystagmus Syndrome ; 5.1.1.1 Association with Strabismus ; 5.1.1.2 Clinical Signs and Symptoms ; 5.1.1.3 Differential Diagnosis ; 5.1.1.4 Reverse-Cover and Gaze-Angle Cover Tests ; 5.1.2 Fusion Maldevelopment Nystagmus Syndrome ; 5.1.2.1 Association with Strabismus ; 5.1.2.2 Clinical Signs and Symptoms ; 5.1.2.3 Differential Diagnosis ; 5.1.2.4 Alternate-Cover and Gaze-Angle Cover Tests ; 5.1.3 Nystagmus Blockage Syndrome ; 5.1.3.1 Association with Strabismus ; 5.1.3.2 Clinical Signs and Symptoms ; 5.1.3.3 Differential Diagnosis ; 5.1.4 Spasmus Nutans Syndrome ; 5.1.4.1 Association with Strabismus ; 5.1.4.2 Clinical Signs and Symptoms ; 5.1.4.3 Differential Diagnosis ; 5.1.5 Nystagmus and Strabismus ; 5.2 NYSTAGMUS WITH ASSOCIATED NEUROLOGICAL DISEASE-<"SYMPTOMATIC>" ; 5.2.1 Vestibular Nystagmus ; 5.2.1.1 Peripheral Vestibular Imbalance ; 5.2.1.2 Central Vestibular Imbalance ; 5.2.1.3 Central Vestibular Instability (Periodic Alternating) ; 5.2.2 Gaze-holding Deficiency Nystagmus ; 5.2.2.1 Eccentric Gaze, Gaze-evoked, Rebound ; 5.2.2.2 Gaze Instability (<"Run-away>") ; 5.2.3 <"Vision-Loss>" Nystagmus ; 5.2.3.1 Pre-chiasmal, Optic Chiasm, Post-chiasmal Vision Loss ; 5.2.4 Other Pendular Nystagmus Associated with Diseases of Central Myelin ; 5.2.4.1 Oculopalatal Tremor or <"Myoclonus>" ; 5.2.4.2 Pendular Vergence Nystagmus Associated with Whipple's Disease ; 5.2.5 Convergence/Convergence Evoked Nystagmus ; 5.2.6 Upbeat Nystagmus ; 5.2.7 Downbeat Nystagmus ; 5.2.8 Torsional Nystagmus ; 5.2.9 <"See-Saw>" Nystagmus ; 5.2.10 Lid Nystagmus ; 5.3 SACCADIC INTRUSIONS/OSCILLATIONS ; 5.3.1 Square Wave Jerks And Oscillations ; 5.3.2 Square-Wave Pulses ; 5.3.3 Staircase Saccadic Intrusions ; 5.3.4 Macrosaccadic Oscillations ; 5.3.5 Saccadic Pulses (Single And Double) ; 5.3.6 Convergence Retraction <"Nystagmus>" ; 5.3.7 Dissociated Ocular Oscillations ; 5.3.8 Dysmetric Saccades ; 5.3.9 Ocular Flutter ; 5.3.10 Flutter Dysmetria ; 5.3.11 Opsoclonus ; 5.3.11.1 Opsoclonus-Myoclonus ; 5.3.12 Superior Oblique Myokymia ; 5.3.13 Ocular bobbing ; 5.3.13.1 Typical ; 5.3.13.2 Monocular ; 5.3.13.3 Atypical ; 5.3.14 Psychogenic (Voluntary) Flutter ; Chapter 6. Afferent Visual System - Clinical Examination Procedures ; 6.1 SUBJECTIVE TESTING ; 6.1.1 Teller Acuity Card Procedure ; 6.1.2 Visual Acuity Testing (High Spatial Frequency Vision) ; 6.1.3 Stereo Testing ; 6.1.4 Color-Vision Testing ; 6.1.5 Contrast-Sensitivity Testing ; 6.1.6 Gaze- and Time-Dependent Acuity Testing ; 6.1.7 Visual Field Testing ; 6.2 OBJECTIVE TESTING ; 6.2.1 Visual Evoked Potentials ; 6.2.2 Electroretinography ; 6.2.3 Optical Coherence Tomography ; 6.2.4 Fundus Photography ; Chapter 7. Treatment ; 7.1 MEDICAL ; 7.1.1 Optical ; 7.1.1.1 Version Prisms ; 7.1.1.2 Vergence Prisms ; 7.1.1.3 Contact Lenses ; 7.1.1.4 Correction of Ammetropia/Anisometropia ; 7.1.1.5 Intraocular Lenses ; 7.1.1.6 Refractive Surgery ; 7.1.2 Pharmacological ; 7.1.2.1 Sedatives/Hypnotics ; 7.1.2.2 Neuroleptics ; 7.1.2.3 Psychoactive Medications ; 7.1.2.4 Antiseizure Medications ; 7.1.2.5 Botulinum ; 7.1.2.6 Anticholinesterases ; 7.2 EYE-MUSCLE SURGERY ; 7.2.1 General Principles ; 7.2.2 Classification ; 7.2.3 Preoperative Evaluation ; 7.2.3.1 Visual Acuity ; 7.2.3.2 Ocular Motor and Standard Clinical Evaluations ; 7.2.3.3 Strabismus ; 7.2.3.4 Eye-Movement Recordings ; 7.2.3.5 Head-Posture Measurements (<"Null Zones>") ; 7.2.3.6 Laboratory and Special Tests ; 7.2.4 Results ; 7.2.4.1 Visual Acuity ; 7.2.4.2 Strabismus ; 7.2.4.3 Eye-Movement Recordings ; 7.2.4.4 Head-Posture Measurements ; 7.2.5 Complications ; 7.3 OTHER ; 7.3.1 Biofeedback ; 7.3.2 Acupuncture ; 7.3.3 Cutaneous Stimulation ; 7.3.4 Gene Transfer Therapy ; 7.3.5 Mind-Body Stress Reduction-Mindful Medication Techniques ; 7.3.6 Occupational and Vision Therapy ; 7.3.7 Educational Assistance ; 7.4 ASSESSING THERAPEUTIC OUTCOMES (POST-THERAPY) ; 7.4.1 Direct Outcome Measures (NAFX, LFD, and Lt) ; 7.4.1.1 Post-Tenotomy & Reattachment ; 7.4.1.2 Post-Convergence/Bimedial Rectus Recession ; 7.4.1.3 Post-Four-Muscle Recession & Resection ; or Two-Muscle Recession + Tenotomy & Reattachment ; 7.4.1.4 Soft Contact Lenses ; 7.4.1.5 Systemic Acetazolamide and Topical Brinzolamide ; 7.4.2 Indirect/Clinical Outcome Measures ; 7.4.2.1 Visual Acuity at Different Gaze Angles ; 7.5 ESTIMATING THERAPEUTIC OUTCOMES (POST-THERAPY) ; 7.5.1 Direct Outcome Measures (NAFX, LFD, and Lt) ; 7.5.1.1 Tenotomy & Reattachment (INS without Afferent Visual Deficits) ; 7.5.1.2 Tenotomy & Reattachment (INS with Afferent Visual Deficits) ; 7.5.1.3 Prisms/Bimedial Rectus Recession ; 7.5.1.4 Soft Contact Lenses ; 7.5.2 Indirect/Clinical Outcome Measures ; 7.5.2.1 Visual Acuity at Different Gaze Angles ; Chapter 8. Summary and Conclusions ; Epilogue ; Appendices ; Appendix A. Eye-Movement Recording Systems and Criteria ; A.1 RECORDING METHODS ; A.1.1 Contact Electrooculography ; A.1.2 Infrared Reflection ; A.1.3 Scleral Search Coil ; A.1.4 High-Speed Video Oculography ; A.2 RESEARCH CRITERIA ; A.2.1 NAFX ; A.2.1.1 Methodology ; A.2.1.2 Estimating Visual Function Improvements ; A.3 CLINICAL CRITERIA ; A.3.1 Waveform Types ; A.3.2 Null and Neutral Zones ; A.3.3 PAN and APAN ; A.3.4 Symmetry, Conjugacy, Vergence, and Monocular Evaluation ; A.4 CALIBRATION TECHNIQUES ; A.4.1 Adults and Children ; A.4.1.1 Infantile Nystagmus ; A.4.1.2 Fusion Maldevelopment Nystagmus ; A.4.2 Infants ; Appendix B. Clinical Examination ; B.1 GENERAL CLINICAL EXAMINATION FORM ; B.2 NYSTAGMUS EXAMINATION FORM ; B.3 STRABISMUS EXAMINATION FORM ; B.4 CLINICAL PEARLS ; B.5 OPHTHALMOLOGICAL MYTHS AND FACTS ; Appendix C. Illustrative Cases and Treatment ; C.1 INFANTILE NYSTAGMUS SYNDROME ; C.1.1 Gaze-Angle Null Only ; C.1.1.1 Version Prisms ; C.1.1.2 Soft Contact Lenses ; C.1.1.3 Four-Muscle Resection, Recession, and Tenotomy & Reattachment ; C.1.1.3.1. Fine Tuning with Prisms ; C.1.1.3.2. Soft Contact Lenses ; C.1.2 Convergence Null Only ; C.1.2.1 Vergence Prisms with Negative Spheres ; C.1.2.2 Soft Contact Lenses ; C.1.2.3 Bimedial Recession ; C.1.3 Both Gaze-Angle and Convergence Nulls ; C.1.3.1 Convergence > Gaze-Angle ; C.1.3.1.1 Composite Prisms and Negative Spheres ; C.1.3.1.2 Base-out Prisms and Negative Spheres ; C.1.3.1.3 Soft Contact Lenses ; C.1.3.1.4 Bimedial Recession ; C.1.3.2 Gaze-Angle > Convergence ; C.1.3.2.1 Version Prisms ; C.1.3.2.2 Soft Contact Lenses ; C.1.3.2.3 Four-Muscle Resection, Recession and ; Tenotomy & Reattachment ; C.1.4 No Nulls ; C.1.4.1 Soft Contact Lenses ; C.1.4.2 Four-Muscle Tenotomy & Reattachment ; C.1.4.2.1 Tenotomy & Reattachment with Augmented ; Tendon Suture ; C.1.4.2.2 Augmented Tendon Suture Procedure sans ; Tenotomy & Reattachment ; C.1.4.3 Faden ; C.2 INFANTILE NYSTAGMUS PLUS STRABISMUS ; C.2.1 Gaze-Angle Null Only ; C.2.1.1 Four-Muscle Resection, Recession and Tenotomy & Reattachment ; C.2.2 Vertical and Torsional Nulls ; C.2.3 No Nulls ; C.2.3.1 Four-Muscle Tenotomy & Reattachment and Strabismus ; C.3 FUSION MALDEVELOPMENT NYSTAGMUS SYNDROME ; C.3.1 Uniocular Fixation ; C.3.2 Alternating Fixation ; C.3.3 Alexander's Law Threshold ; C.4 NYSTAGMUS BLOCKAGE SYNDROME ; C.4.1 Bimedial Recession (plus Tenotomy & Reattachment) ; C.4.2 Recession and Resection plus Tenotomy & Reattachment ; C.4.3 Four-Muscle Tenotomy & Reattachment ; Appendix D. Diagnosis and Treatment Flow Charts ; D.1 WAVEFORM-BASED DIAGNOSES ; D.2 THERAPEUTICALLY EXPLOITABLE WAVEFORM CHARACTERISTICS ; D.3 CLINICALLY BASED DIAGNOSES AND LIMITATIONS ; D.4 THERAPEUTICALLY EXPLOITABLE CLINICAL CHARACTERISTICS ; D.5 ANALYSIS GRAPHS ; Appendix E. Included Compact Disk and On-Line Access Videos ; E.1 <"EYEBALLS 3D>" EYE-MOTION AND WAVEFORM VIDEOS ; MV1 INS (PPfs) 1 cycle 1/20-speed illustrating foveation period ; MV2 INS (Jef) 4 cycles 1/3-speed with phase plane ; MV3 INS (PPfs) 3 cycles 1/2-speed illustrating well-developed foveation ; MV4 INS (PPfs) 3 cycles 1/5-speed with phase plane ; MV5 INS (PPfs) 1/2-speed 3-dimensional motion with subclinical SSN ; MV6 INS 1/5-speed Subclinical SSN motion amplified ; MV7 INS PPfs 1/2-speed from OMS model and patient ; MV8 INS (Pfs) step responses OMS model ; MV9 INS (PPfs) 1/2-speed pulse responses OMS model ; MV10 INS (PPfs) 1/2-speed OMS model ramp and step-ramp responses ; MV11 FMNS gaze-angle effect OMS model ; MV12 FMNS 1/2-speed alternate cover test OMS model ; MV13 FMNS adducting eye fixation OMS model ; MV14 INS damping with rapid convergence ; MV15 INS 1/2-speed pre-T&R ; MV16 INS 1/2-speed post-T&R ; MV17 INS 1/2-speed RPE65-deficient canine pre-gene therapy MV18 INS 1/2-speed RPE65-deficient canine pre-gene therapy scan path ; MV19 INS 1/2-speed RPE65-deficient canine post-gene therapy MV20 INS 1/2-speed RPE65-deficient canine post-gene therapy scan path ; MV21 Oscillopsia simulation ; MV22 Uniocular APN pre- and post-therapy ; MV23 INS (alternating J) OMS model ; E.1.1 PowerPoint Files ; E.1.1 E1_INS Dynamic VA ; E.1.2 E1_INS Latency Poster ; E.1.3 E1_ INS Latency ; E.1.4 E1_ INS Model Poster ; E.2 CANINE VIDEOS (PLUS OTHERS) ; CV1 Normal Brittany ; CV2 Achiasmatic Belgian Sheepdog: pre-T&R ; CV3 Achiasmatic Belgian Sheepdog: post-T&R ; CV4 RPE65-deficient canine: pre-gene therapy behavior ; CV5 RPE65-deficient canine: post-gene therapy behavior ; CV6 RPE65-deficient canine: pre-gene therapy eye movements ; CV7 RPE65-deficient canine: post-gene therapy eye movements ; CV8 Cat with INS ; CV9 Goat with SSN ; E.3 PATIENT VIDEOS ; PV1 Saccadic Initiation Failure ; PV2 Brainstem Tumor: Tonic Gaze Deviation ; PV3 Acquired Downbeat Nystagmus ; PV4 Acquired Gaze-Evoked (Gaze-Holding Failure) Nystagmus ; PV5 Acquired Unidirectional Gaze-Evoked (Gaze-Holding Failure) Nystagmus ; PV6 Ocular Motor Neuromyotonia of Cranial Nerve III ; PV7 Ocular Motor Neuromyotonia of Cranial Nerve VI ; PV8 Infant with Opsoclonus (Ocular Flutter - <"Saccadomania>") ; PV9 Acquired Saccadic Oscillations-1 ; PV10 Acquired Saccadic Oscillations-2 ; PV11Acquired Saccadic Oscillations-3 ; PV12 Acquired Nystagmus + Saccadic Oscillations ; PV13 Acquired Upbeat Nystagmus with Wiernecke's Encephalopathy ; PV14 Acquired Vertical Pendular Nystagmus ; PV15 Fusion Maldevelopment Nystagmus-1 ; PV16 Fusion Maldevelopment Nystagmus-2 ; PV17 Down Syndrome and Infantile Nystagmus ; PV18 Achiasma + See-Saw Nystagmus + Infantile Nystagmus ; PV19 Octogenarian with Infantile Nystagmus ; PV20 Infantile Nystagmus: Aperiodically Changing Intensity (Not Direction) ; PV21 Infantile Nystagmus: Aperiodically Changing Direction (Not Intensity) ; PV22 Infantile Nystagmus: Unequal-1 ; PV23 Infantile Nystagmus: Unequal-2 ; PV24 Infantile Nystagmus: Unequal-3 ; PV25 Infantile Nystagmus: Jerk with Extended Foveation ; PV26 Infantile + NOT Nystagmus: Dual Jerk ; PV27 Infantile Nystagmus: Pre- and Post-Operative ; PV28 Optic Nerve Dysplasia and Infantile Nystagmus: Multiplanar ; PV29 Infantile Nystagmus: Jerk with Extended Foveation ; PV30 Infantile Nystagmus: Unequal with a <"latent component>" ; PV31 Albinism and Infantile Nystagmus ; PV32 Optic Nerve Dysplasia and Infantile Nystagmus: Multiplanar ; PV33 Albinism, Up-gaze Null, and Infantile Nystagmus: Equal ; PV34 Retinal Dystrophy and Infantile Nystagmus: Multiplanar ; PV35 Albinism and Infantile Nystagmus: Pre- and Post-Operative Horizontal Null ; PV36 Albinism and Infantile Nystagmus: Multiplanar ; PV37 Infantile Nystagmus: Periodic Alternating ; PV38 Infantile Nystagmus: Asymmetric Aperiodic Alternating ; PV39 Albinism and Infantile Nystagmus: Pre- and Post-Operative Vertical Null ; PV40 Albinism, Up-gaze Null, and Infantile Nystagmus ; PV41 Albinism and Infantile Nystagmus ; PV42 <"Vertical>" Infantile Nystagmus-1 ; PV43 Retinal Dystrophy and <"Vertical>" Infantile Nystagmus-2 ; PV44 Spasmus Nutans Nystagmus-1 ; PV45 Spasmus Nutans Nystagmus-2 ; PV46 Voluntary Ocular Flutter ; Appendix F. Included Compact Disk and On-Line Access ; F.1 OMLAB REPORTS ; F.1.1 #011105 Recording and Calibrating the Eye Movements of Nystagmus Subjects ; F.1.2 #111005 Using the NAFX for Eye-Movement Fixation Data Analysis and Display ; F.1.3 #111905 Nystagmus Therapies: Types, Sites, and Measures ; F.1.4 #090506 Original Ocular Motor Analysis of the First Human with Achiasma: ; Documentation of Work Done in 1994 ; F.1.5 #123007 The Benefits of Extraocular Muscle Surgery in INS ; F.1.6 #030509 How Someone <"Sees>" the World and How to Clinically Assess ; Therapeutic Improvements in Visual Function ; F.2 PATIENT HANDOUTS ; F.2.1 INS Information ; F.2.2 INS Treatments ; F.2.3 Tenotomy and Reattachment ; F.2.4 INS and Acuity ; F.2.5 INS Miscellaneous ; F.3 PHYSICIAN/RESEARCH SCIENTIST WORKSHEETS ; F.3.1 Recession and Resection Surgical Calculation ; F.3.2 Estimating Improvement in Peak NAFX ; F.3.3 Estimating Improvement in LFD ; F.3.4 NAFX vs. Visual Acuity (Motor and Sensory Components) ; F.4 CLINICAL EXAMINATION FORMS ; F.4.1 General Clinical Examination Form ; F.4.2 Nystagmus Examination Form ; F.4.3 Strabismus Examination Form ; F.5 ANALYSIS SOFTWARE ; F.5.1 OMtools ; F.5.2 OMS Model GUI User Guide
